Factor 8 Gene Roctavian denied for missing prior authorization by Cigna?

Cigna's specific coverage criteria for factor 8 gene roctavian are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna Denied Roctavian (valoctocogene roxaparvovec) — Prior Authorization Required

Roctavian is a high-cost, one-time gene therapy, and Cigna requires advance prior authorization (PA) before it will cover the infusion. A prior-auth-required denial means either that no PA was obtained before the procedure, that the PA request was submitted but not approved before the infusion was administered, or that a PA was approved for a different product or indication. Given the logistical complexity of gene therapy — which involves HTC scheduling, pre-treatment screening, and infusion center coordination — PA timing issues are common and do not reflect on the clinical appropriateness of the treatment.

## Why This Denial Is Appealable

If Roctavian was administered in an urgent or emergent clinical context where obtaining advance PA was not feasible, that is a strong basis for a retrospective appeal. If the PA was submitted and not responded to in time, Cigna's failure to act within regulatory timeframes may itself be a basis for appeal. If the PA was denied on clinical grounds before the infusion and the infusion proceeded anyway (e.g., based on clinical urgency), document that decision clearly. Even in non-urgent cases, if the PA process was followed correctly and a denial was issued without a clinically adequate review, the denial can be challenged.

## Federal Appeal Framework

• Internal appeal: File within 180 days of the denial. For a procedure of this magnitude, request a peer-to-peer review between the treating hematologist and Cigna's medical director as the first step.
• Retrospective appeal: If the infusion was already administered, submit a retrospective PA request with full clinical documentation simultaneously with the appeal.
• External review (ACA §2719): After exhausting internal appeal, request independent external review within four months of the final internal denial. External reviewers assess whether Cigna's PA denial criteria were clinically appropriate.
• ERISA §503: Employer plan members are entitled to the full PA criteria applied, the reviewing clinician's qualifications, and the right to submit additional information.
• State prompt-pay and PA timing laws: Many states require Cigna to respond to PA requests within defined timeframes; if those were not met, cite the applicable state law in the appeal.

## Documentation to Gather

1. PA submission records — copies of all PA requests submitted, submission dates, reference numbers, and any Cigna responses. 2. Timeline documentation — a chronological summary of when the PA was submitted relative to the scheduled and actual infusion date. 3. Clinical urgency documentation — if the infusion proceeded without or before PA approval, a clinical note from the treating hematologist explaining the clinical necessity and urgency. 4. HTC evaluation and candidacy records — comprehensive records from the hemophilia treatment center documenting the pre-treatment evaluation, screening results, and the decision to proceed. 5. Prescriber medical-necessity letter — a detailed letter addressing each of Cigna's PA criteria for Roctavian, with specific chart facts supporting each criterion. 6. Cigna's PA criteria for Roctavian — download the current medical/coverage policy and use it as the appeal's organizational framework. 7. FDA prescribing label — the approved indication section confirms the clinical basis for the treatment.

## Criteria-Mapping Structure

Address both the procedural and clinical dimensions of the appeal: - Procedural column: Show that the PA process was followed correctly (or document why it could not be, with clinical justification). - Clinical column: Map each PA criterion from Cigna's policy to the specific chart fact that satisfies it.

Attach all supporting documents as numbered exhibits. If the denial is retrospective, explicitly request that Cigna conduct a concurrent review of both the procedural and clinical grounds.